Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Raymond, Scott B ^a,b   Treat, Lisa H ^a,c   Dewey, Jonathan D ^d   McDannold, Nathan J ^c   Hynynen, Kullervo ^e   Bacskai, Brian J ^b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA ANTIBODY; GADOLINIUM; PROTEIN ANTIBODY; TRYPAN BLUE; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IMMUNOTHERAPY; MICROBUBBLE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STRAIN DIFFERENCE; ULTRASOUND THERAPY; ANIMAL; DISEASE MODEL; FLUORESCENCE; TRANSGENIC MOUSE;

MUS MUSCULUS;

ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; FLUORESCENCE; MICE; MICE, TRANSGENIC; ULTRASONIC THERAPY;

EID: 48249140247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002175     Document Type: Article

References (39)

1. Shi N, Pardridge WM (2000) Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A 97: 7567-7572.
2. Wu D, Pardridge WM. (1999) Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc Natl Acad Sci U S A 96: 254-259.
3. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220: 640-646.
4. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N (2005) Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24: 12-20.
5. Hynynen K, Clement CT, McDannold N, Vykhodtseva N, King R, et al. (2004) 500-clement ultrasound phased array system for noninvasive focal surgery of the brain: A preliminary rabbit study with ex vivo human skulls. Magnetic Resonance in Medicine 52: 100-107.
6. Kinoshita M, McDannold N, Jolesz FA, Hynynen K (2006) Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proceedings of the National Academy of Sciences of the United States of America 103: 11719-11723.
7. Kinoshita M, McDannold N, Jolesz FA, Hynynen K (2006) Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochemical and Biophysical Research Communications 340: 1085-1090.
8. Treat LH, McDannold N, Vykhodtseva N, Zhang YZ, Tam K, et al. (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. International Journal of Cancer 121: 901-907.
9. Ingelsson M, Hyman B (2002) Disordered proteins in dementia. Ann Med 34: 259-271.
10. Hüll M, Berger M, Heneka M (2006) Disease-modifying therapies in Alzheimer's disease: how far have we come? Drugs 66: 2075-2093.
11. Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, et al. (2007) Recent advances in the development of amyloid imaging agents. Curr Top Med Chem 7: 1773-1789.
12. Hawkes C, McLaurin J (2007) Immunotherapy as treatment for Alzheimer's disease. Expert Rev Neurother 7: 1535-1548.
13. Skowronek M, Roterman I, Konieczny L, Stopa B, Rybarska J, et al. (2000) The conformational characteristics of Congo red, Evans blue and Trypan blue. Computers & Chemistry 24: 429-450.
14. Macklin CC, Macklin MT (1920) A study of brain repair in the rat by the use of trypan blue-With special reference to the vital staining of the macrophages. Archives of Neurology and Psychiatry 3: 353-U315.
15. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527.
16. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K (2005) MRI-guided targeted blood-brain barrier disruption with focused ultrasound: Histological findings in rabbits. Ultrasound in Medicine and Biology 31: 1527-1537.
17. Dickstein D, Biron K, Ujiie M, Pfeifer C, Jeffries A, et al. (2006) Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20: 426-433.
18. Ujiie M, Dickstein D, Carlow D, Jefferies W (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10: 463-470.
19. Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K (2001) Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Neurobiology of Disease 8: 555-567.
20. Fryer J, Taylor J, DeMattos R, Bales K, Paul S, et al. (2003) Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J Neurosci 23: 7889-7896.
21. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K (2004) Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound in Medicine and Biology 30: 979-989.
22. Raymond SB, Skoch J, Hynynen K, Bacskai BJ (2007) Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. Journal of Cerebral Blood Flow and Metabolism 27: 393-403.
23. Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, et al. (2006) Brain anterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound in Medicine and Biology 32: 1399-1409.
24. Choi JJ, Pernot M, Small SA, Konofagou EE (2007) Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound in Medicine and Biology 33: 95-104.
25. Yang F, Fu W, Yang R, Liou H, Kang K, et al. (2007) Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med Biol 33: 1421-1427.
26. Sigurdsson E, Wadghiri Y, Mosconi L, Blind J, Knudsen E, et al. (2007) A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging.
27. Poduslo JF, Ramakrishnan M, Holasek SS, Ramirez-Alvarado M, Kandimalla KK, et al. (2007) In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques. Journal of Neurochemistry 102: 420-433.
28. Thakker D, Natt F, Hüsken D, Maier R, Müller M, et al. (2004) Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A 101: 17270-17275.
29. Senechal Y, Kelly P, Cryan J, Natt F, Dev K (2007) Amyloid precursor protein knockdown by siRNA impairs spontaneous alternation in adult mice. J Neurochem 102: 1928-1940.
30. Bard F, Cannon C, Barbour R, Burke RL, Games D, et al. (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6: 916-919.
31. Bard F, Barbour R, Cannon C, Carretto R, Fox M, et al. (2003) Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci U S A 100: 2023-2028.
32. Gardberg AS, Dice LT, Ou S, Rich RL, Helmbrecht E, et al. (2007) Molecular basis for passive immunotherapy of Alzheimer's disease. Proc Natl Acad Sci U S A 104: 15659-15664.
33. Nikolic WV, Bai Y, Obregon D, Hou H, Mori T, et al. (2007) Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage. Proc Natl Acad Sci U S A 101: 2507-2512.
34. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, et al. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: 306-319.
35. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, et al. (2006) [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67: 446-452.
36. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, et al. (2007) Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 130: 2837-2844.
37. Hynynen K, McDannold N, Clement G, Jolesz FA, Zadicario E, et al. (2006) Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain-A primate study. European Journal of Radiology 59: 149-156.
38. McDannold N, Jolesz F (2000) Magnetic resonance image-guided thermal ablations. Top Magn Reson Imaging 11: 191-202.
39. Abramoff M, Magelhaes P, Ram S (2004) Image processing with ImageJ. Biophotonics International. pp 36-42.